Work

Frequency of Transition From Stage A to Stage B Heart Failure After Initiating Potentially Cardiotoxic Chemotherapy

Year: 2018

Type: article

Study design: Observational Study

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2018.08.005

Authors: Deanna N. Jones, Jennifer H. Jordan, Giselle C. Meléndez, Zanetta Lamar, Alexandra Thomas, Dalane W. Kitzman, Cynthia Suerken, Ralph B. D’Agostino, W. Gregory Hundley

Institutions: Wake Forest University Health Sciences, Wake Forest University, Virginia Commonwealth University, Virginia Commonwealth University Medical Center

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Susan G. Komen for the Cure, GlaxoSmithKline, Gilead Sciences, National Institutes of Health, Relypsa, National Cancer Institute, Duke Clinical Research Institute

Awards: G2348675747, G3707413662, G424083508, G8074540523, G9000040850

OpenAlex ID: W2900326348

FWCI: 3.266

Cites: 37

Cited by: 26

Related to: 10